TSC112#4r2c4
The cell line is not validated yet.
IMBAi022-A-1
General
Cell Line |
|
| hPSCreg name | IMBAi022-A-1 |
| Cite as: | IMBAi022-A-1 |
| Alternative name(s) |
TSC112#4r2c4
|
| Cell line type | Human induced pluripotent stem cell (hiPSC) |
| Similar lines | No similar lines found. |
| Last update | 22nd January 2025 |
| User feedback | |
Provider |
|
| Generator | Institute of Molecular Biotechnology (IMBA) |
| Derivation country | Austria |
External Databases |
|
| BioSamples | SAMEA117616014 |
General Information |
|
| * Is the cell line readily obtainable for third parties? |
Yes Research use: allowed
Clinical use: not allowed
Commercial use: allowed
|
| Subclone of | |
Donor Information
General Donor Information |
|
| Sex | female |
Phenotype and Disease related information (Donor) |
|
| Diseases | A disease was diagnosed.
|
External Databases (Donor) |
|
| BioSamples | SAMEA117616013 |
Ethics
Also have a look at the ethics information for the parental line
IMBAi022-A
.
| For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used? |
hIPSC Derivation
General |
|
|
The source cell information can be found in the parental cell line
IMBAi022-A.
|
|
Reprogramming method |
|
Vector free reprogramming |
|
Other |
|
| Derived under xeno-free conditions |
Unknown |
| Derived under GMP? |
Unknown |
| Available as clinical grade? |
Unknown |
Culture Conditions
Characterisation
Analysis of Undifferentiated Cells
| Marker | Expressed | Immunostaining | RT-PCR | Flow Cytometry | Enzymatic Assay | Expression Profiles |
| SSEA-4 |
Yes |
|
||||
| SSEA5 |
Yes |
|
||||
| TRA 1-60 |
Yes |
|
Differentiation Potency
In vitro directed differentiation
In vitro directed differentiation
Genotyping
Karyotyping (Cell Line) |
|
Other Genotyping (Cell Line) |
Genetic Modification
| Genetic modifications not related to a disease |
|
Login to share your feedback, experiences or results with the research community.